By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mitsubishi Tanabe Pharma Corporation 

3-2-10, Dosho-machi, Chuo-ku

Osaka    541-8505  Japan
Phone: n/a Fax: n/a



Company News
Mitsubishi Tanabe Presents Edaravone Clinical Trial Data In ALS At 2016 American Academy of Neurology Annual Meeting 4/20/2016 2:41:22 PM
Mitsubishi Tanabe Signs Licensing Agreement With A. Menarini Asia-Pacific For Spedra (Avanafil) In 10 Countries In Asia-Pacific 2/26/2016 10:03:37 AM
Akebia (AKBA) And Mitsubishi Tanabe Announce Collaboration To Develop And Commercialize Vadadustat In Asia 12/14/2015 1:13:29 PM
Regeneron (REGN) Forges $325 Million Pain Pact with Mitsubishi Tanabe 10/2/2015 6:10:16 AM
MedImmune (AZN) And Tanabe Research Laboratories U.S.A., Inc./Mitsubishi Tanabe Enter Into Strategic Collaboration And Licensing Agreement For The Development Of Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugates To Treat Cancer 9/23/2015 1:52:15 PM
Neurocrine Biosciences, Inc. (NBIX) And Mitsubishi Tanabe Pharma Corporation Announce Agreement To Develop And Commercialize VMAT2 Inhibitor NBI-98854 For Movement Disorders In Japan And Other Select Asian Markets 4/1/2015 12:52:31 PM
AstraZeneca PLC (AZN), Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research 8/20/2014 6:24:16 AM
Mitsubishi Tanabe Pharma Corporation Completes Acquisiton of Medicago, Inc. 9/18/2013 9:22:26 AM
Medicago, Inc. Announces Receipt of Final Court Order and Regulatory Approvals for Arrangement With Mitsubishi Tanabe Pharma Corporation 9/12/2013 9:29:10 AM
Medicago, Inc. Shareholders Approve Arrangement Wth Mitsubishi Tanabe Pharma Corporation 8/30/2013 8:47:46 AM